Clinical trial
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an…
NCT00073476 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00073476 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke |
| Official title | A Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101,606 in Subjects With Acute Ischemic Stroke. |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | traxiprodil (CP-101, 606) |
| Enrollment | 300 |
| Start date | Sep 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Nov 24, 2003 |
| Last update posted | Jun 22, 2006 |
| Countries | Estonia, Germany, Hungary, Italy, Portugal, Singapore, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: